Farallon Capital Management »

Erasca shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $291k 18k 16.18

More positions owned by Farallon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option
Revolution Medicines (RVMD)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Aon Shs Cl A (AON)
Bridgebio Pharma (BBIO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option
Protagonist Therapeutics (PTGX)
Natera (NTRA)
Exelixis (EXEL)
Broadcom (AVGO)
UnitedHealth (UNH)
Synopsys (SNPS)
Boston Scientific Corporation (BSX)
Thermo Fisher Scientific (TMO)

View all positions for Farallon Capital Management

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
VR Adviser
Rtw Investments
Vivo Capital
Vanguard Capital Management
Siren
Logos Global Management
Paradigm Biocapital Advisors
State Street Corporation
Arch Venture Corp
Geode Capital Management
Cormorant Asset Management
Affinity Asset Advisors
Balyasny Asset Management

View all funds holding Erasca